Pharmaceutical

BioNTech and CEPI partner to develop Mpox vaccine

BioNTech has entered a strategic collaboration with the CEPI to develop mRNA-based vaccine candidates for monkeypox (Mpox ) prevention.

Sep 19, 2023 - 20:00
BioNTech and CEPI partner to develop Mpox vaccine
BioNTech has entered a strategic collaboration with the CEPI to develop mRNA-based vaccine candidates for monkeypox (Mpox ) prevention.
Read the original article

Tags:

Previous Article

Orexo announces NDA submission to FDA for opioid overdose therapy

Next Article

Pharmanovia announces acquisition of Sanofi’s CNS brands

What's Your Reaction?

like

dislike

love

funny

angry

sad

wow

Related Posts

Pfizer announces drop in reported net income in Q2 2023

Pfizer announces drop in reported net income in Q2 2023

Aug 2, 2023

CS Pharmaceuticals snaps up AxeroVision to shore up ophthalmology portfolio

CS Pharmaceuticals snaps up AxeroVision to shore up oph...

Aug 2, 2023

Opinion: Former Sen. Max Baucus: Breakthrough Alzheimer’s drugs are out of reach for many in rural states like Montana

Opinion: Former Sen. Max Baucus: Breakthrough Alzheimer...

Aug 3, 2023